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additional sugar residues attached to mycosamine. A disaccharide-modified nystatin has been isolated from Pseudonocardia species P1, a symbiont of leafcutting ants.
11) The second sugar residue has not been fully identified, but is thought to be a hexose. The gene for the extending GT has been identified and was named nypY. Lee and co-workers characterized another nystatin analog, produced
by Pseudonocardia autotrophica. 12) This polyene contains an N-acetylglucosamine residue -1,4 linked to the mycosaminyl sugar residue. The new compound is less hemolytic than nystatin, and more than 300 times more water-soluble. The gene for this extending GT was not found in the main biosynthetic gene cluster.
Actinoplanes caeruleus synthesizes 67-121C (1), an aromatic heptaene that is modified with a mannosyl-mycosaminyl disaccharide. Co-metabolites such as 67-121A (2) are produced in smaller amounts; these contain a single mycosaminyl sugar ( Fig. 1) . 13, 14) In this study we identified the late genes involved in 67-121 biosynthesis and assessed the activities of the encoded enzymes towards aglycones of amphotericin B (3), a medically important polyene synthesized by Streptomyces nodosus. In this bacterium, the amphotericin PKS produces 8-deoxy-16-descarboxyl-16-methyl-amphoteronolides B (4) and A (8) . The AmphN P450
forms C-16 carboxyl groups, to give 8-deoxyamphoteronolides B (5) and A (9).
The AmphDI GT catalyzes mycosaminylation, and finally AmphL, another P450, catalyzes hydroxylation at C-8 to give amphotericins B and A (3 and 7). 15) Mutant strains deficient in the late steps have been generated. 16, 17) These were used as hosts for heterologous expression of A. caeruleus polyene modification genes.
A. caeruleus DSM43900 was purchased from Leibniz Institute DSMZ, the German collection of micro-organisms and cell cultures (Braunschweig, Germany). Production of 1 was confirmed by growing starter cultures on GYE medium (2% w/v glucose, 1% w/v yeast extract, and 2% w/v CaCO 3 ) and production cultures on fructose-dextrin-soya production medium.
18)
Methanol extracts of the mycelia contained a major heptaene with activity against
Saccharomyces cerevisiae. and genomic DNA was isolated using a Qiagen 500/G column. The manufacturer's instructions were followed. Genome sequencing was carried out by BaseClear (Leiden, Netherlands) using an Illumina instrument (Illumina Inc., San Diego, California, USA).
The genome sequence analysis yielded 2,194 contigs with an average size of 3,696 bp. The total length of DNA sequenced was 8,109,345 bp. This was adequate for the present study. Efforts to obtain an improved genome sequence are in progress. The sequences were annotated using the Artemis program (downloaded from http://www.sanger.ac.uk/resources/software/artemis/). One 10,697bp contig was found to contain homologs of known mycosaminyltransferase, mycosamine synthase, cytochrome P450 and ferredoxin enzymes and proteins. The highest levels of sequence identity were 68% for GT, 79% for mycosamine synthase, 69% for P450, and 54% for ferredoxin. The A.
caeruleus genes were named aceDI, aceDII, aceN, and aceM, respectively.
Adjacent genes encoded an editing thioesterase, a p-aminobenzoic acid synthase, and a putative PKS loading module. The order of genes was identical to that in the FR008/candicidin biosynthetic gene cluster. 19) BLAST searches were carried out with the remaining contigs to identify the gene encoding the GT that adds the second sugar residue. Another 9,988bp sequence contained the most likely candidate, which was named pegA (putative polyene extending glycosyltransferase). The protein was homologous (48% sequence identity overall)
to known mycosaminyl transferases. The degrees of sequence identity were 39%
for the N-terminal acceptor-binding domain and 60% for the C-terminal region, which binds the GDP-sugar donor substrate. Recombinant GTs are used to glycosylate natural products in vitro. 20) This approach yields only small amounts of glycosylated material, but is a sensitive method of assessing substrate tolerance. Our attempts to overproduce PegA were unsuccessful. A recombinant form with a C-terminal hexahistidine tag was overproduced in Escherichia coli from a pET28 construct, but the protein was insoluble. pIAGO constructs were designed to express forms with N-terminal or C-terminal tags in Streptomyces lividans. These did not give detectable levels of recombinant proteins, even after Ni-NTA resins were used to enrich the target protein by affinity purification.
This study provides new information on the substrate specificities of glycosyltransferases and cytochrome P450 enzymes that act on aromatic polyenes.
Despite the high degree of sequence homology between AmphN and AceN (69% identity), the latter enzyme only weakly recognized amphoteronolide substrates.
To date it has not been possible to overproduce an active recombinant cytochrome P450 that forms an exocyclic carboxyl group in a polyene macrolide. The mechanism of action of these enzymes can be investigated by expressing engineered versions in streptomycete hosts that produce macrolactone substrates.
It might be possible to engineer the biosynthesis of amphotericin analogs in which the methyl branch at C-16 is oxidized to a hydroxyl group rather than a carboxylic acid. The A. caeruleus GTs showed little activity towards amphotericin substrates.
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